RxSight, Inc. Research And Development Expense

Quick Answer

RxSight, Inc. reported Research And Development Expense of $38.55 million for the year ending 2025.

  • RxSight, Inc. showed an increase of +12.2% in Research And Development Expense from 2024 to 2025.
  • This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), RxSight, Inc.'s Research And Development Expense has grown by 75.7%.
  • Historical annual values: Fiscal year 2025: $38.55 million | Fiscal year 2024: $34.37 million | Fiscal year 2023: $29.05 million | Fiscal year 2022: $25.98 million | Fiscal year 2021: $24.50 million | Fiscal year 2020: $21.93 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: